North America Whole Exome Sequencing Market - Industry Trends and Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION 13

• 1.1 OBJECTIVES OF THE STUDY 13
• 1.2 MARKET DEFINITION 13
• 1.3 OVERVIEW OF NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET 13
• 1.4 CURRENCY AND PRICING 15
• 1.5 LIMITATIONS 15
• 1.6 MARKETS COVERED 16

2 MARKET SEGMENTATION 18

• 2.1 MARKETS COVERED 18
• 2.2 GEOGRAPHICAL SCOPE 19
• 2.3 YEARS CONSIDERED FOR THE STUDY 19
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 20
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23
• 2.6 MULTIVARIATE MODELLING 24
• 2.7 MARKET APPLICATION COVERAGE GRID 25
• 2.8 PRODUCT TYPE LIFELINE CURVE 26
• 2.9 DBMR MARKET POSITION GRID 27
• 2.10 SECONDARY SOURCES 28
• 2.11 ASSUMPTIONS 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHT 32

• 4.1 PORTER'S FIVE FORCES 33
• 4.2 PESTEL ANALYSIS 34
• 4.3 INDUSTRIAL INSIGHTS: 35
• 4.4 CONCLUSION 36

5 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: REGULATIONS 37

6 MARKET OVERVIEW 39

• 6.1 DRIVERS 41
  • 6.1.1 GROWING USAGE OF TARGETED SEQUENCING METHODS 41
  • 6.1.2 INCREASE IN THE ADOPTION OF NEXT GENERATION SEQUENCING 41
  • 6.1.3 INCREASING DIAGNOSTICS APPLICATIONS OF WHOLE EXOME SEQUENCING 41
  • 6.1.4 INCREASE TREND TOWARD PERSONALIZED MEDICATION 42 
• 6.2 RESTRAINTS 43
  • 6.2.1 LESS COMPREHENSIVE COVERAGE OF EXONS 43
  • 6.2.2 CYBER SECURITY CONCERNS IN GENOMICS 43
• 6.3 OPPORTUNITIES 44
  • 6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER 44
  • 6.3.2 INCREASING PRODUCT LAUNCHES IN RECENT YEARS 44
• 6.4 CHALLENGES 45
  • 6.4.1 LACK OF SKILLED PROFESSIONALS 45
  • 6.4.2 ETHICAL AND LEGAL ISSUES RELATED TO WHOLE EXOME SEQUENCING 45

7 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT 46

• 7.1 OVERVIEW 47
• 7.2 SECOND-GENERATION SEQUENCING 50
  • 7.2.1 SEQUENCING BY SYNTHESIS (SBS) 51
  • 7.2.2 SEQUENCING BY HYBRIDIZATION (SBH) AND SEQUENCING BY LIGATION (SBL) 51
• 7.3 THIRD-GENERATION SEQUENCING 52

8 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE 53

• 8.1 OVERVIEW 54
• 8.2 SYSTEMS 57
  • 8.2.1 HISEQ SERIES 57
    • 8.2.1.1 HISEQ 2500 58
    • 8.2.1.2 HISEQ 1500 58
  • 8.2.2 MISEQ SERIES 58
  • 8.2.3 ION TORRENT PLATFORMS 59
    • 8.2.3.1 ION PROTON 59
    • 8.2.3.2 ION PGM 59
  • 8.2.4 OTHERS 59
• 8.3 KITS 59
  • 8.3.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS 60
  • 8.3.2 LIBRARY PREPARATION KITS 60
  • 8.3.3 TARGET ENRICHMENT KITS 61
  • 8.3.4 OTHERS 61
• 8.4 SERVICES 61
  • 8.4.1 SEQUENCING SERVICES 62
  • 8.4.2 DATA ANALYSIS (BIOINFORMATICS) SERVICES 62
  • 8.4.3 OTHERS 62 

9 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION 63

• 9.1 OVERVIEW 64
• 9.2 DRUG DISCOVERY AND DEVELOPMENT 67
• 9.3 AGRICULTURE & ANIMAL RESEARCH 67
• 9.4 DIAGNOSTICS 68
• 9.5 PERSONALIZED MEDICINE 68
• 9.6 OTHERS 69

10 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY END USER 70

• 10.1 OVERVIEW 71
• 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 74
• 10.3 ACADEMIC & RESEARCH INSTITUTES 75
• 10.4 HOSPITALS AND CLINICS 75
• 10.5 CLINICAL LABORATORIES 75
• 10.6 OTHERS 76

11 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL 77

• 11.1 OVERVIEW 78
• 11.2 DIRECT TRADE 81
• 11.3 RETAIL SALES 81
• 11.4 OTHERS 82

12 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY REGION 83

• 12.1 NORTH AMERICA 84
  • 12.1.1 U.S. 88
  • 12.1.2 CANADA 91
  • 12.1.3 MEXICO 94

13 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: COMPANY LANDSCAPE 97

• 13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 97

14 COMPANY PROFILE 98

• 14.1 PERKINELMER GENOMICS (A SUBSIDIARY OF PERKINELMER INC.) 98
  • 14.1.1 COMPANY SNAPSHOT 98
  • 14.1.2 PRODUCT PORTFOLIO 98
  • 14.1.3 RECENT DEVELOPMENTS 99 
• 14.2 MERCK KGAA 100
  • 14.2.1 COMPANY SNAPSHOT 100
  • 14.2.2 REVENUE ANALYSIS 100
  • 14.2.3 PRODUCT PORTFOLIO 101
  • 14.2.4 RECENT DEVELOPMENTS 101
• 14.3 EXODX (A PART OF BIO-TECHNE) 102
  • 14.3.1 COMPANY SNAPSHOT 102
  • 14.3.2 PRODUCT PORTFOLIO 102
  • 14.3.3 RECENT DEVELOPMENTS 102
• 14.4 THERMO FISHER SCIENTIFIC INC. 103
  • 14.4.1 COMPANY SNAPSHOT 103
  • 14.4.2 REVENUE ANALYSIS 103
  • 14.4.3 PRODUCT PORTFOLIO 104
  • 14.4.4 RECENT DEVELOPMENTS 104
• 14.5 FOUNDATION MEDICINE, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD) 105
  • 14.5.1 COMPANY SNAPSHOT 105
  • 14.5.2 PRODUCT PORTFOLIO 105
  • 14.5.3 RECENT DEVELOPMENTS 106
• 14.6 AZENTA US, INC. 107
  • 14.6.1 COMPANY SNAPSHOT 107
  • 14.6.2 PRODUCT PORTFOLIO 107
  • 14.6.3 RECENT DEVELOPMENTS 108
• 14.7 BECKMAN COULTER, INC 109
  • 14.7.1 COMPANY SNAPSHOT 109
  • 14.7.2 PRODUCT PORTFOLIO 109
  • 14.7.3 RECENT DEVELOPMENTS 110
• 14.8 CD GENOMICS 111
  • 14.8.1 COMPANY SNAPSHOT 111
  • 14.8.2 PRODUCT PORTFOLIO 111
  • 14.8.3 RECENT DEVELOPMENTS 111
• 14.9 EUROFINS SCIENTIFIC 112
  • 14.9.1 COMPANY SNAPSHOT 112
  • 14.9.2 REVENUE ANALYSIS 112
  • 14.9.3 PRODUCT PORTFOLIO 113
  • 14.9.4 RECENT DEVELOPMENTS 113
• 14.10 GENEDX, LLC 114
  • 14.10.1 COMPANY SNAPSHOT 114
  • 14.10.2 PRODUCT PORTFOLIO 114
  • 14.10.3 RECENT DEVELOPMENTS 115 
• 14.11 GENEFIRST LIMITED. 116
  • 14.11.1 COMPANY SNAPSHOT 116
  • 14.11.2 PRODUCT PORTFOLIO 116
  • 14.11.3 RECENT DEVELOPMENTS 116
• 14.12 ILLUMINA, INC 117
  • 14.12.1 COMPANY SNAPSHOT 117
  • 14.12.2 REVENUE ANALYSIS 117
  • 14.12.3 PRODUCT PORTFOLIO 118
  • 14.12.4 RECENT DEVELOPMENTS 118
• 14.13 INTEGRATED DNA TECHNOLOGIES, INC. 119
  • 14.13.1 COMPANY SNAPSHOT 119
  • 14.13.2 PRODUCT PORTFOLIO 119
  • 14.13.3 RECENT DEVELOPMENTS 120
• 14.14 MERIDIAN BIOSCIENCE, INC. 121
  • 14.14.1 COMPANY SNAPSHOT 121
  • 14.14.2 REVENUE ANALYSIS 121
  • 14.14.3 PRODUCT PORTFOLIO 122
  • 14.14.4 RECENT DEVELOPMENTS 122
• 14.15 PSOMAGEN 123
  • 14.15.1 COMPANY SNAPSHOT 123
  • 14.15.2 REVENUE ANALYSIS 123
  • 14.15.3 PRODUCT PORTFOLIO 124
  • 14.15.4 RECENT DEVELOPMENTS 124
• 14.16 QIAGEN 125
  • 14.16.1 COMPANY SNAPSHOT 125
  • 14.16.2 REVENUE ANALYSIS 125
  • 14.16.3 PRODUCT PORTFOLIO 126
  • 14.16.4 RECENT DEVELOPMENTS 126
• 14.17 SOPHIA GENETICS 127
  • 14.17.1 COMPANY SNAPSHOT 127
  • 14.17.2 REVENUE ANALYSIS 127
  • 14.17.3 PRODUCT PORTFOLIO 128
  • 14.17.4 RECENT DEVELOPMENTS 128
• 14.18 TWIST BIOSCIENCE 129
  • 14.18.1 COMPANY SNAPSHOT 129
  • 14.18.2 REVENUE ANALYSIS 129
  • 14.18.3 PRODUCT PORTFOLIO 130
  • 14.18.4 RECENT DEVELOPMENTS 130 

15 QUESTIONNAIRE 131

16 RELATED REPORTS 134

LIST OF TABLES

• TABLE 1 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION) 49
• TABLE 2 NORTH AMERICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION) 51
• TABLE 3 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 56
• TABLE 4 GLOBAL SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 57
• TABLE 5 GLOBAL HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 58
• TABLE 6 NORTH AMERICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 59
• TABLE 7 NORTH AMERICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 60
• TABLE 8 NORTH AMERICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 62
• TABLE 9 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2021- 2030 (USD MILLION) 66
• TABLE 10 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2021- 2030 (USD MILLION) 73
• TABLE 11 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2021- 2030 (USD MILLION) 80
• TABLE 12 U.S. WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION) 88
• TABLE 13 U.S. SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION) 88
• TABLE 14 U.S. WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 88
• TABLE 15 U.S. SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 88
• TABLE 16 U.S. HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 89
• TABLE 17 U.S. ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 89
• TABLE 18 U.S. KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 89
• TABLE 19 U.S. SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 89
• TABLE 20 U.S. WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2021- 2030 (USD MILLION) 90
• TABLE 21 U.S. WHOLE EXOME SEQUENCING MARKET, BY END USER, 2021- 2030 (USD MILLION) 90
• TABLE 22 U.S. WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2021- 2030 (USD MILLION) 90
• TABLE 23 CANADA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION) 91
• TABLE 24 CANADA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION) 91
• TABLE 25 CANADA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 91
• TABLE 26 CANADA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 91
• TABLE 27 CANADA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 92
• TABLE 28 CANADA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 92
• TABLE 29 CANADA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 92
• TABLE 30 CANADA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 92
• TABLE 31 CANADA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2021- 2030 (USD MILLION) 93
• TABLE 32 CANADA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2021- 2030 (USD MILLION) 93
• TABLE 33 CANADA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2021- 2030 (USD MILLION) 93
• TABLE 34 MEXICO WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION) 94
• TABLE 35 MEXICO SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2021- 2030 (USD MILLION) 94
• TABLE 36 MEXICO WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 94
• TABLE 37 MEXICO SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 94
• TABLE 38 MEXICO HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 95
• TABLE 39 MEXICO ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 95
• TABLE 40 MEXICO KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 95
• TABLE 41 MEXICO SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2021- 2030 (USD MILLION) 95
• TABLE 42 MEXICO WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2021- 2030 (USD MILLION) 96
• TABLE 43 MEXICO WHOLE EXOME SEQUENCING MARKET, BY END USER, 2021- 2030 (USD MILLION) 96
• TABLE 44 MEXICO WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2021- 2030 (USD MILLION) 96

LIST OF FIGURES

• FIGURE 1 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION 18
• FIGURE 2 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: DATA TRIANGULATION 20
• FIGURE 3 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: DROC ANALYSIS 21
• FIGURE 4 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 22
• FIGURE 5 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: COMPANY RESEARCH ANALYSIS 22
• FIGURE 6 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: INTERVIEW DEMOGRAPHICS 23
• FIGURE 7 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: MARKET APPLICATION COVERAGE GRID 25
• FIGURE 8 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: DBMR MARKET POSITION GRID 27
• FIGURE 9 NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION 31
• FIGURE 10 INCREASE IN USE OF WES TECHNOLOGY FOR NEW SCIENTIFIC APPLICATIONS AND INCREASING THE PREFERENCE OF WES OVER WHOLE-GENOME SEQUENCING IS ITS LOW-COST SEQUENCING CAPABILITY IS EXPECTED TO DRIVE THE NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET IN THE FORECAST PERIOD OF 2023 TO 2030 32
• FIGURE 11 THE COMPONENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA WHOLE EXOME SEQUENCING (WES) MARKET IN 2023 & 2030 32
• FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA WHOLE EXOME SEQUENCING MARKET 40
• FIGURE 13 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2022 47
• FIGURE 14 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2022-2029 (USD MILLION) 48
• FIGURE 15 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, CAGR (2022-2029) 48
• FIGURE 16 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, LIFELINE CURVE 49
• FIGURE 17 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2022 54
• FIGURE 18 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2023-2030 (USD MILLION) 55
• FIGURE 19 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, CAGR (2023-2030) 55
• FIGURE 20 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE 56
• FIGURE 21 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2022 64
• FIGURE 22 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 65
• FIGURE 23 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, CAGR (2023-2030) 65
• FIGURE 24 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, LIFELINE CURVE 66
• FIGURE 25 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, 2022 71
• FIGURE 26 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, 2023-2030 (USD MILLION) 72
• FIGURE 27 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, CAGR (2023-2030) 72
• FIGURE 28 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY END USER, LIFELINE CURVE 73
• FIGURE 29 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2022 78
• FIGURE 30 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 79
• FIGURE 31 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 79
• FIGURE 32 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 80
• FIGURE 33 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2022) 85
• FIGURE 34 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022) 86
• FIGURE 35 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2023 & 2030) 86
• FIGURE 36 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2030) 87
• FIGURE 37 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2023-2030) 87
• FIGURE 38 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2022 (%) 97